Clinical Trial Update: Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION [Phase 1, Phase 2]

View source ↗

Summary

This report describes a Phase 1/2 clinical trial evaluating radioembolization as second-line therapy for unresectable cholangiocarcinoma, which has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cholestasis, Progressive Familial Intrahepatic 3 | Phase 1, Phase 2 | Status: TERMINATED